Game Creek Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,000
Closed -$2.15M 103
2025
Q4
$2.15M Buy
+2,000
New +$1.91M 0.71% 50

Other funds holding LLY

Game Creek Capital's LLY Position: Q2 2026 in Review

Game Creek Capital reduced its Eli Lilly (LLY) stake by 23% in Q2 2026, selling an estimated $1.59M and leaving 5,070 shares worth $6.08M. The position accounts for 2.15% of the portfolio, ranked #13.

Game Creek Capital first reported a position in LLY in Q4 2017 and has held it in 6 quarters since. The position peaked at $7.25M in Q4 2025. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Game Creek Capital held 5,070 shares of Eli Lilly worth $6.08M as of Q2 2026.
  • Game Creek Capital sold 1,555 Eli Lilly shares in Q2 2026, an estimated $1.59M.
  • Eli Lilly made up 2.15% of Game Creek Capital's portfolio in Q2 2026, its #13 holding.
  • Game Creek Capital first reported a position in Eli Lilly in Q4 2017 and has held it in 6 quarters since.
  • Game Creek Capital's Eli Lilly position peaked at $7.25M in Q4 2025.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Game Creek Capital's 13F filing for Q2 2026, filed 13 Aug 2026.